The "Mad Money" host said Mirum Pharmaceuticals, Inc. is losing too much money. "You know what, I feel so bad about that because when they’re up like that, and they’re doing some great work in that particular disease, particularly with the liver, I want to recommend it. But I just am afraid to because it’s had such a big move," he added.
TRIUMPHANT RETURNS : As long as jim cramer is not Bullish I m buyin.
Cramer ETF OP TRIUMPHANT RETURNS :